88 related articles for article (PubMed ID: 21117502)
1. Synthesis and in vitro human skin penetration of oligo- and polymeric ethylene glycol carbonates of zidovudine and stavudine.
N'Da DD; Breytenbach JC; Breytenbach JW
Arzneimittelforschung; 2010; 60(9):575-82. PubMed ID: 21117502
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.
N'da DD; Breytenbach JC
J Pharm Pharmacol; 2009 Jun; 61(6):721-31. PubMed ID: 19505362
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro transdermal penetration of methoxypoly(ethylene glycol) carbonate derivatives of stavudine.
N'Da DD; Breytenbach JC; Legoabe LJ; Breytenbach JW
Med Chem; 2009 Nov; 5(6):497-506. PubMed ID: 19673696
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E
ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro transdermal penetration of methoxypoly(ethylene glycol) carbonate and carbamate derivatives of lamivudine (3TC).
van Heerden J; Breytenbach JC; N'Da DD; Breytenbach JW; du Preez JL
Med Chem; 2010 Mar; 6(2):91-9. PubMed ID: 20158460
[TBL] [Abstract][Full Text] [Related]
7. Molecularly imprinted polymer for analysis of zidovudine and stavudine in human serum by liquid chromatography-mass spectrometry.
Duy SV; Lefebvre-Tournier I; Pichon V; Hugon-Chapuis F; Puy JY; Périgaud C
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1101-8. PubMed ID: 19299211
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and transdermal penetration of stavudine-5'-esters.
Holmes EM; Breytenbach JC; Gerber M; du Plessis J
Med Chem; 2010 Sep; 6(5):271-6. PubMed ID: 20977413
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action.
Thomas NS; Panchagnula R
Eur J Pharm Sci; 2003 Jan; 18(1):71-9. PubMed ID: 12554075
[TBL] [Abstract][Full Text] [Related]
10. Combination strategies to enhance transdermal permeation of zidovudine (AZT).
Thomas NS; Panchagnula R
Pharmazie; 2003 Dec; 58(12):895-8. PubMed ID: 14703969
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
Uckun FM; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Microemulsion and Lamellar Liquid Crystalline Systems for Transdermal Zidovudine Delivery.
Carvalho AL; Silva JA; Lira AA; Conceição TM; Nunes Rde S; de Albuquerque Junior RL; Sarmento VH; Leal LB; de Santana DP
J Pharm Sci; 2016 Jul; 105(7):2188-93. PubMed ID: 27220471
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
Quevedo MA; Briñón MC
Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
[TBL] [Abstract][Full Text] [Related]
14. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of beta-D-3'-azido-2',3'-unsaturated nucleosides and beta-D-3'-azido-3'-deoxyribofuranosylnucleosides.
Gadthula S; Chu CK; Schinazi RF
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1707-27. PubMed ID: 16438043
[TBL] [Abstract][Full Text] [Related]
16. Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways.
Sqalli-Houssaini H; Pierlot C; Kusnierz JP; Parmentier B; Martin-Nizard F; Lestavel-Delattre S; Tartar A; Fruchart JC; Sergheraert C; Duriez P
Biotechnol Ther; 1994; 5(1-2):69-85. PubMed ID: 7703834
[TBL] [Abstract][Full Text] [Related]
17. Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometry.
Pruvost A; Becher F; Bardouille P; Guerrero C; Creminon C; Delfraissy JF; Goujard C; Grassi J; Benech H
Rapid Commun Mass Spectrom; 2001; 15(16):1401-8. PubMed ID: 11507751
[TBL] [Abstract][Full Text] [Related]
18. Large-scale synthesis and formulation of GMP-grade stampidine, a new anti-HIV agent.
DuMez D; Venkatachalam TK; Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):136-51. PubMed ID: 16570822
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new homo and heterodinucleosides containing the 2',3'-dideoxynucleosides AZT and D4T.
Taourirte M; Lazrek HB; Vasseur JJ; Ferrero M; Fernandez S; Gotor V
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):959-62. PubMed ID: 11563154
[TBL] [Abstract][Full Text] [Related]
20. Disposition of [1'-(14)C]stavudine after oral administration to humans.
Zhou L; Kaul S; Liu-Kreyche P; Tran SB; Espina RR; Warrack BM; Roongta VA; Iyer RA
Drug Metab Dispos; 2010 Apr; 38(4):655-66. PubMed ID: 20053818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
